Sex differences in the development of CKD complications

Gianmarco Lombardi1, Elisa De Tomi1, Chiara Lenoci1

  • 1Section of Nephrology, Department of Medicine, Università degli Studi di Verona, Verona, Italy.

Insights

Men with chronic kidney disease (CKD) experience faster declines in hemoglobin and acidosis and a greater rise in parathyroid hormone. However, these sex-specific CKD complication patterns did not impact mortality risk.

Area of Science:

  • Nephrology
  • Internal Medicine
  • Clinical Research

Background:

  • Limited evidence exists on sex-based differences in chronic kidney disease (CKD) complications, often relying on cross-sectional data.
  • This study addresses this gap by longitudinally examining CKD complication parameters and sex-specific differences.

Purpose of the Study:

  • To longitudinally assess clinical and biochemical markers of CKD complications.
  • To identify and compare sex-specific trajectories of CKD complications.
  • To investigate the association of these complications with mortality in men and women.

Main Methods:

  • Retrospective analysis of the CRIC cohort with 10-year follow-up.
  • Inclusion of adults with baseline eGFR 20-70 mL/min/1.73 m².
  • Longitudinal evaluation of hemoglobin, CO2, potassium, phosphate, PTH, and SBP using mixed-effects models and Cox regression for mortality, with sex-stratified analyses.

Main Results:

  • Men showed higher prevalence of anemia, acidosis, hyperkalemia, and hyperparathyroidism; women had more hyperphosphatemia.
  • Longitudinally, worsening eGFR correlated with declining Hb, CO2, SBP, and increasing K+, phosphate, and iPTH.
  • Men exhibited steeper declines in Hb and CO2 and a more pronounced rise in iPTH compared to women. Men had higher all-cause mortality.

Conclusions:

  • Significant sex-specific differences exist in the progression of CKD complications, with men experiencing more rapid changes in key parameters.
  • Despite differing complication trajectories, sex did not influence mortality risk associated with these specific CKD complications.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
820
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
758
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
503
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
267
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
363
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
274